CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Ordinary Shares	Capital in Excess of Par Value	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Beginning Equity Balance at Dec. 31, 2022	$ 2	$ 581,893	$ 6,047	$ (470,204)	$ 117,738
Beginning Equity Balance (shares) at Dec. 31, 2022	48,477,209
Share based compensation activity		5,201			5,201
Share based compensation activity (shares)	209,054
Other comprehensive loss			(2,353)		(2,353)
Net loss for the period ended March 31				(30,364)	(30,364)
Ending Equity Balance at Mar. 31, 2023	$ 2	587,094	3,694	(500,568)	90,222
Ending Equity Balance (shares) at Mar. 31, 2023	48,686,263
Beginning Equity Balance at Dec. 31, 2023	$ 2	693,841	(1,435)	(554,231)	138,177
Beginning Equity Balance (shares) at Dec. 31, 2023	63,601,015
Share based compensation activity		4,739			4,739
Share based compensation activity (shares)	441,348
Issuance of shares in at-the-market offering		1,586			1,586
Issuance of shares in at-the-market offering (shares)	256,328
Issuance costs in connection with ordinary shares		(635)			(635)
Other comprehensive loss			(1,691)		(1,691)
Net loss for the period ended March 31				(20,442)	(20,442)
Ending Equity Balance at Mar. 31, 2024	$ 2	$ 699,531	$ (3,126)	$ (574,673)	$ 121,734
Ending Equity Balance (shares) at Mar. 31, 2024	64,298,691